Home   Logon   Mobile Site   Research and Commentary   About Us   Call 1.800.621.1675 or Email Us       Follow Us: 

Search by Ticker, Keyword or CUSIP       
 
 


 

Tactical Alpha Portfolio, Series 20
Ticker Symbol: FURACX

50 Holdings (As of Day of Deposit)
Ticker Company Name Initial
Weight
Price*
Sectors (60%)
Financials (20%)
BAC Bank of America Corporation 2% $28.65
COF Capital One Financial Corporation 2% 81.37
C Citigroup Inc. 2% 62.06
CFG Citizens Financial Group, Inc. 2% 34.76
GS The Goldman Sachs Group, Inc. 2% 195.24
JPM JPMorgan Chase & Co. 2% 103.01
KEY KeyCorp 2% 16.77
MS Morgan Stanley 2% 41.36
PRU Prudential Financial, Inc. 2% 93.30
AMTD TD Ameritrade Holding Corporation 2% 54.25
Health Care (20%)
ALXN Alexion Pharmaceuticals, Inc. 2% 128.68
ANTM Anthem, Inc. 2% 295.04
CI Cigna Corporation 2% 163.14
HCA HCA Healthcare, Inc. 2% 124.74
JNJ Johnson & Johnson 2% 138.06
MRK Merck & Co., Inc. 2% 79.80
SYK Stryker Corporation 2% 187.23
TMO Thermo Fisher Scientific Inc. 2% 249.85
UNH UnitedHealth Group Incorporated 2% 237.29
VRTX Vertex Pharmaceuticals Incorporated 2% 177.26
Technology (20%)
AAPL Apple Inc. 2% 172.91
AVGO Broadcom Inc. 2% 264.19
CDW CDW Corporation 2% 92.30
CSCO Cisco Systems, Inc. 2% 51.07
INTC Intel Corporation 2% 52.48
KEYS Keysight Technologies, Inc. 2% 83.99
MSFT Microsoft Corporation 2% 110.51
PANW Palo Alto Networks, Inc. 2% 234.63
V Visa Inc. 2% 147.35
ZBRA Zebra Technologies Corporation 2% 201.90
Themes (40%)
Cloud Computing (10%)
ADBE Adobe Incorporated 2% 254.74
GOOG Alphabet Inc. 2% 1,142.32
AMZN Amazon.com, Inc. 2% 1,620.80
FB Facebook, Inc. 2% 169.60
CRM salesforce.com, inc. 2% 155.06
Inflation Hedge (10%)
COP ConocoPhillips 2% 65.43
KL Kirkland Lake Gold Ltd. 2% 34.94
NUE Nucor Corporation 2% 57.79
RIO Rio Tinto Plc 2% 54.66
RDS/B Royal Dutch Shell Plc 2% 61.96
SMID Capital Strength (20%)
EME EMCOR Group, Inc. 2% 70.41
EVR Evercore Inc. 2% 88.09
HQY HealthEquity, Inc. 2% 74.84
NSP Insperity, Inc. 2% 121.58
MKSI MKS Instruments, Inc. 2% 78.45
ODFL Old Dominion Freight Line, Inc. 2% 142.71
OSK Oshkosh Corporation 2% 77.64
PRAH PRA Health Sciences, Inc. 2% 101.85
PUMP ProPetro Holding Corp. 2% 19.25
SUPN Supernus Pharmaceuticals, Inc. 2% 37.61

* As of the close of business on 3/8/19.
Market values are for reference only and are not indicative of your individual cost basis.

Not FDIC Insured • Not Bank Guaranteed • May Lose Value

Portfolio Summary
Initial Date of Deposit 3/11/2019
Initial Public Offering Price $10.00 per Unit
Portfolio Ending Date 6/11/2020
Cash CUSIP 30310U345
Reinvestment CUSIP 30310U352
Fee Accounts Cash CUSIP 30310U360
Fee Accounts Reinvestment CUSIP 30310U378

Sales Charges (based on a $10 public offering price)
Standard Accounts
Transactional Sales Charges: Initial: 0.00%
  Deferred: 1.35%
Creation & Development Fee:   0.50%
Maximum Sales Charge:   1.85%

The deferred sales charge will be deducted in three monthly installments commencing 6/20/19.

When the public offering price is less than or equal to $10.00 per unit, there will be no initial sales charge. If the price exceeds $10.00 per unit, you will pay an initial sales charge.

Fee/Wrap Accounts
Maximum Sales Charge: 0.50%

The maximum sales charge for investors in fee accounts consists of the creation and development fee. Investors in fee accounts are not assessed any transactional sales charges. Standard accounts sales charges apply to units purchased as an ineligible asset.

The creation and development fee is a charge of $.050 per unit collected at the end of the initial offering period. If the price you pay exceeds $10 per unit, the creation and development fee will be less than 0.50%; if the price you pay is less than $10 per unit, the creation and development fee will exceed 0.50%.

In addition to the sales charges listed, UITs are subject to annual operating expenses and organization costs.

You should consider the portfolio's investment objective, risks, and charges and expenses carefully before investing. Contact your financial advisor or call First Trust Portfolios, L.P. at 1.800.621.1675 to request a prospectus, which contains this and other information about the portfolio. Read it carefully before you invest.

Risk Considerations:
An investment in this unmanaged unit investment trust should be made with an understanding of the risks involved with owning common stocks, such as an economic recession and the possible deterioration of either the financial condition of the issuers of the equity securities or the general condition of the stock market.

You should be aware that the portfolio is concentrated in stocks in both the health care and information technology sectors which involves additional risks, including limited diversification. The companies engaged in the health care sector are subject to fierce competition, high research and development costs, governmental regulations, loss of patent protection, and changing consumer spending trends. In addition, the Health Care and Education Affordability Reconciliation Act of 2010 has had and will continue to have a significant impact on the health care sector. The companies engaged in the information technology sector are subject to fierce competition, high research and development costs, and their products and services may be subject to rapid obsolescence. Technology company stocks, especially those which are Internet-related, may experience extreme price and volume fluctuations that are often unrelated to their operating performance.

An investment in a portfolio containing equity securities of foreign issuers is subject to additional risks, including currency fluctuations, political risks, withholding, the lack of adequate financial information, and exchange control restrictions impacting foreign issuers.

An investment in a portfolio containing small-cap and mid-cap companies is subject to additional risks, as the share prices of small-cap companies and certain mid-cap companies are often more volatile than those of larger companies due to several factors, including limited trading volumes, products, financial resources, management inexperience and less publicly available information.

Although this portfolio terminates in approximately 15 months, the strategy is long-term. Investors should consider their ability to pursue investing in successive portfolios, if available. There may be tax consequences unless units are purchased in an IRA or other qualified plan.

As the use of Internet technology has become more prevalent in the course of business, the trust has become more susceptible to potential operational risks through breaches in cyber security.

The value of the securities held by the trust may be subject to steep declines or increased volatility due to changes in performance or perception of the issuers.

 
Fund Cusip Information
30310U345 (Cash)
30310U352 (Reinvest)
30310U360 (Cash-Fee)
30310U378 (Reinvest-Fee)
Printer Friendly Page Printer Friendly Page
 
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial advisors are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
First Trust Portfolios L.P.  Member SIPC and FINRA.
First Trust Advisors L.P.
Home |  Important Legal Information |  Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2019 All rights reserved.